McSwain Hugh, Shaw Corey, Hall Lee D
Department of Radiology, Naval Medical Center San Diego, San Diego, California, USA.
J Vasc Interv Radiol. 2005 Jul;16(7):1007-12. doi: 10.1097/01.RVI.0000158353.35161.90.
An effective transcervical method for fluoroscopically guided fallopian tube occlusion has long been sought for female sterilization. The Essure permanent birth control device was approved by the Food and Drug Administration in November 2002 and is currently indicated for hysteroscopic placement. In a series of eight patients, bilateral Essure microcoils were placed with fluoroscopic guidance in seven patients for a success rate of 87.5%. One patient described peri- and postprocedure pelvic pain, otherwise no complications were identified. All patients returned to normal activities within 24 hours. Fluoroscopically guided transcervical tubal sterilization with the Essure microcoil device (Conceptus, San Carlos, CA) is a viable outpatient procedure.
长期以来，人们一直在寻求一种有效的经宫颈方法，用于在荧光镜引导下进行输卵管闭塞以实现女性绝育。依索优尔永久避孕装置于2002年11月获得美国食品药品监督管理局批准，目前适用于宫腔镜放置。在一组8例患者中，7例患者在荧光镜引导下放置了双侧依索优尔微线圈，成功率为87.5%。1例患者描述了术中和术后的盆腔疼痛，除此之外未发现并发症。所有患者均在24小时内恢复正常活动。使用依索优尔微线圈装置（Conceptus，加利福尼亚州圣卡洛斯）进行荧光镜引导下经宫颈输卵管绝育术是一种可行的门诊手术。
